President-elect Joe Biden wants to drop Medicare’s eligibility age to 60. If he succeeds, the move might bring in well more than 20 million new enrollees. What are the odds he’ll plant that piece of a potentially sweeping healthcare agenda?  

Will the public be braced enough for the expected side effects of shot No. 1 that they’ll follow through with the essential second round?

The temporary telehealth reforms put in place to help the U.S. weather the COVID-19 storm “are good for patients and should be made permanent.”

Improving the patient experience will top the list of hospitals’ strategies for winning and retaining patients in 2021. Not far behind will be facilitating access to care.

A healthcare research firm specializing in purchasing has considered the post-election landscape from the vantage point of large employers offering health benefits to their workers.

As Joe Biden makes plans to intensify the federal response to the COVID crisis, he can expect support on that agenda item from 77% of Democrats, 62% of independents, 55% of Republicans and 50% of others.

The COVID crisis will spur leaders of life sciences companies around the world to focus on longstanding pain points that AI could help alleviate. And the execs are looking to put their money where their responses are.

When it comes to predicting an individual’s risk of suffering a heart attack or stroke over the next 10 years, machine learning models are no more consistent than traditional statistical techniques.

Cardiologists push their patients to stay active, often emphasizing the link between physical activity and a healthy cardiovascular system. Many doctors, however, aren't listening to their own advice.